OPRX Financials 07/16/2014 19:16:33 OptimizeRx Co

OPRX Financials 07/16/2014 19:16:33
OptimizeRx Corp.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 4,957 1,989 1,112 71
Cost of Revenue 1,767 115 - -
Gross Profit 3,190 1,874 1,112 71
Operating Expenses
Research and Development - - - -
Sales, General and Admin. 2,974 2,329 2,565 1,917
Non-Recurring Items - - - -
Other - - - -
Operating Income 216 (455) (1,454) (1,846)
Income From Continuing Operations
Add'l Income/Expense Items - - 292 (56)
Earnings Before Interest and Tax 216 (454) (1,162) (1,902)
Interest Expense - - 959 107
Earnings Before Tax 216 (455) (2,121) (2,009)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 216 (455) (2,121) (2,009)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 216 (455) (2,121) (2,009)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 216 (455) (2,121) (2,009)